A recent study utilizing scRNA seq on BM CD8+ T cells demonstrated gradual deterioration of clonal diversity in newly diagnosed AML patients followed by relapsed/refractory (R/R) AML patients, compared to healthy individuals [150], a finding also observed by Feng et al. [152]. Here, CD8A is linked to acute myeloid leukemia.